Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereof
US-2024101580-A1 · Mar 28, 2024 · US
US9034849B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9034849-B2 |
| Application number | US-201113019262-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 1, 2011 |
| Priority date | Feb 3, 2010 |
| Publication date | May 19, 2015 |
| Grant date | May 19, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides fatty acid amide hydrolase inhibitors, solid forms thereof, compositions thereof, and methods of making and using the same.
Opening claim text (preview).
We claim: 1. A solid form comprising a crystalline compound of formula 1: or a pharmaceutically acceptable salt, hydrate, or solvate thereof, wherein the crystalline compound of formula 1 is a Form A crystal form of formula 1 having an X-ray powder diffraction pattern comprising peaks at approximate peak positions of 17.26±0.10, 21.60±0.10, and 27.73±0.10 degrees 2θ and a…
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.